LYB

Business Profile & Competitive Position

LyondellBasell Industries N.V. (LYB) sits in the Basic Materials sector and is classified under Chemicals - Specialty. The company operates across petrochemicals, polymers, refining, and related downstream products, selling resins, plastics, and specialty chemicals into packaging, construction, automotive, and consumer goods end markets. Because it straddles commodity and differentiated chemical lines, its results are tied both to global manufacturing demand and to the ability to maintain product premiums.

The current margin and return data do not point to a wide defensive moat today. The firm’s net margin is -1.1% and its return on equity (ROE) is -3.4%. Negative profitability means LYB is not currently earning its cost of equity, and pricing power is being squeezed somewhere along the value chain—whether through weak product spreads, lower volumes, or higher feedstock and operating costs. In specialty chemicals, durable moats usually show up as stable or expanding margins and mid-to-high single-digit (or better) ROEs; the present negative figures argue the business is operating below that threshold and is more cyclically exposed than a narrowly defined "specialty" label might suggest.

Financial Posture

LYB’s current financial snapshot is dominated by loss-generation, not traditional valuation. The stock’s market capitalization is $19.2 billion, yet the trailing P/E ratio is -53.2 because earnings are negative. A negative P/E is a signal that the market is pricing the company on something other than current net income—typically asset value, recovery expectations, dividend capacity, or normalized cycle earnings.

The profitability metrics reinforce the same story: a net margin of -1.1% and an ROE of -3.4% indicate the business is consuming capital rather than compounding it on a trailing basis. The beta of 0.36 is unusually low for a materials name, suggesting the stock has moved less than one-third as much as the broad market over the measured period. That could reflect a large-cap, diversified, dividend-paying profile, but it is not the same as stability in fundamentals. At the current snapshot, the share price is $59.595, below the 50-day EMA of $61.14, with an RSI of 49.0—essentially neutral and not extended in either direction.

Macro & Geopolitical Exposure

As a Basic Materials / Chemicals - Specialty company, LYB is exposed to several macro variables that move in cycles rather than in straight lines. Feedstock costs are first on the list: natural gas liquids, ethane, propane, crude oil, and refinery inputs are the raw materials for many of its products. When feedstock costs rise faster than selling prices, chemical spreads compress and margins contract.

Second, regulation and environmental policy matter. Petrochemical operations face emissions, waste, and permitting rules in North America, Europe, and Asia; stricter standards can increase capital intensity and slow capacity additions. Third, trade policy and currency swings influence competitiveness. Chemicals are globally traded, so tariffs, import duties, and a strong dollar can make U.S.-produced resins less attractive abroad or cheaper imports more competitive at home. Fourth, supply-chain logistics—rail, port, and pipeline availability—affect working capital and delivery reliability. Finally, end-market demand is cyclical: packaging, autos, construction, and durable goods all track industrial production, interest rates, and consumer confidence.

Recent Developments

The most recent headlines frame a stock caught between value watchers and near-term bearish fundamental signals.

• On August 7, 2026, GuruFocus flagged LYB after a 3.0% decline, noting a GuruFocus Value of $72.71 versus the then-price of $59.59.
• On August 6, 2026, Defense World reported that Empowered Funds LLC boosted its holdings in LyondellBasell.
• On August 5, 2026, another GuruFocus article asked whether LYB was a bargain following a 3.4% drop, again pointing to GuruFocus Value as signaling undervaluation.
• On August 3, 2026, Zacks published coverage of the Q2 earnings call, summarizing management’s message as pointing to a "prolonged supply reset."

Read together, the news flow shows institutional buyers adding shares and valuation models flagging a discount, while the company’s own commentary emphasizes an industry supply imbalance that is unlikely to clear quickly. That tension—value label versus fundamental reset—is the central narrative around the name in early August.

Earnings Behavior & Post-Earnings Drift

LYB’s earnings history over the last eight quarters is a useful case study in why headline beats and misses do not always translate into predictable price follow-through. Over that span, the company has beaten estimates 4 out of 8 times (50%), but the average earnings surprise is -28.6%—a sign that the misses have been larger than the beats in percentage terms. The average five-trading-day move after those reports is -0.8%, classified as a downward post-earnings drift.

The real disconnect shows up in the most recent quarters. In the last four reports:

• July 31, 2026: EPS of $4.30 beat the $3.44 estimate by 25%, yet the stock fell 2.35% the next day and 4.01% over the following five sessions.
• May 1, 2026: EPS of $0.49 beat the $0.2806 estimate by 74.6%; the stock rose 1.4% the next day but gave it back and more, dropping 4.31% over five days.
• January 30, 2026: EPS of -$0.26 missed the $0.1113 estimate by -333.6%; the stock rallied 2.55% the next day and surged 12.45% over the next five sessions.
• October 31, 2025: EPS of $1.01 beat the $0.811 estimate by 24.5%; the stock slipped 0.32% the next day and fell 7.32% over five days.

Three of those four quarters were beats, yet only one produced a positive one-day reaction, and none delivered a positive five-day drift. The pattern suggests the market’s real expectation goes beyond the published consensus: investors appear to sell good quarters on the assumption that the next quarter or the cycle outlook will weaken, while a reported miss can be shrugged off if it already embeds a near-term low. The next report is scheduled for October 30, 2026, before the open, with the current consensus EPS estimate at $2.81. That figure will be measured not just against reported results, but against what the price action implies about whether the "prolonged supply reset" is still extending.

For a fuller picture of how sell-side and institutional models are weighing the supply reset, valuation discount, and earnings trajectory, readers should review the complete institutional verdict and aggregated analyst estimates rather than relying on headline numbers alone.